Use of Direct-Acting Oral Anticoagulants in Patients With Atrial Fibrillation and Chronic Liver Disease

Theresa J Hydes^{1

2}, Gregory Y H Lip^{1

3

4}, Deirdre A Lane^{1

3

4}

Affiliations

¹ Department of Cardiovascular and Metabolic Medicine, Institute of Life Course and Medical Sciences, University of Liverpool, UK (T.J.H., G.Y.H.L., D.A.L.).
² Liverpool University Hospitals National Health Service Foundation Trust, Aintree University Hospital, Lower Lane, UK (T.J.H.).
³ Liverpool Centre for Cardiovascular Science, University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital, UK (G.Y.H.L., D.A.L.).
⁴ Department of Clinical Medicine, Aalborg University, Denmark (G.Y.H.L., D.A.L.).

Editorial

Theresa J Hydes et al. Circulation. 2023.

. 2023 Mar 7;147(10):795-797.

doi: 10.1161/CIRCULATIONAHA.122.063195. Epub 2023 Mar 6.

Theresa J Hydes^{1

2}, Gregory Y H Lip^{1

3

4}, Deirdre A Lane^{1

3

4}

¹ Department of Cardiovascular and Metabolic Medicine, Institute of Life Course and Medical Sciences, University of Liverpool, UK (T.J.H., G.Y.H.L., D.A.L.).
² Liverpool University Hospitals National Health Service Foundation Trust, Aintree University Hospital, Lower Lane, UK (T.J.H.).
³ Liverpool Centre for Cardiovascular Science, University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital, UK (G.Y.H.L., D.A.L.).
⁴ Department of Clinical Medicine, Aalborg University, Denmark (G.Y.H.L., D.A.L.).

No abstract available

Keywords: Editorials; atrial fibrillation; chronic liver disease; direct-acting oral anticoagulants.

Dataset described in

Comparative Effectiveness and Safety of Direct Oral Anticoagulants and Warfarin in Patients With Atrial Fibrillation and Chronic Liver Disease: A Nationwide Cohort Study.
Lawal OD, Aronow HD, Shobayo F, Hume AL, Taveira TH, Matson KL, Zhang Y, Wen X. Lawal OD, et al. Circulation. 2023 Mar 7;147(10):782-794. doi: 10.1161/CIRCULATIONAHA.122.060687. Epub 2023 Feb 10. Circulation. 2023. PMID: 36762560